# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Earlier this month, biotech giant Amgen Inc (NASDAQ: AMGN)
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...
Companies Reporting Before The Bell • BioDelivery Sciences Intl (NASDAQ:BDSI) is estimated to report quarterly earnings at ...
Five Prime Therapeutics (NASDAQ:FPRX) releases its next round of earnings this Wednesday, March 10. Get the latest predictions ...
Guggenheim analyst Etzer Darout downgrades Five Prime Therapeutics (NASDAQ:FPRX) from Buy to Neutral and announces $38 price...
Biotech stocks continued to move southward in the week ended March 5, as the broader market extended its sell-off. Though light...